MD930Y - Method for treating genital herpes - Google Patents

Method for treating genital herpes Download PDF

Info

Publication number
MD930Y
MD930Y MDS20140122A MDS20140122A MD930Y MD 930 Y MD930 Y MD 930Y MD S20140122 A MDS20140122 A MD S20140122A MD S20140122 A MDS20140122 A MD S20140122A MD 930 Y MD930 Y MD 930Y
Authority
MD
Moldova
Prior art keywords
vincetoxicum
genital herpes
treating genital
hirundinaria
sulfur
Prior art date
Application number
MDS20140122A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Ştefan GAŢCAN
Petru Stratulat
Stanislav Godovanciuc
Ion MEREUŢA
Original Assignee
Ştefan GAŢCAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ştefan GAŢCAN filed Critical Ştefan GAŢCAN
Priority to MDS20140122A priority Critical patent/MD930Z/en
Publication of MD930Y publication Critical patent/MD930Y/en
Publication of MD930Z publication Critical patent/MD930Z/en

Links

Landscapes

  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

The invention relates to medicine, particularly to obstetrics and gynecology and can be used for treating genital herpes.According to the invention, the claimed method consists in that it is administered, intramuscularly, once a day, a mixture consisting of a homeopathic preparation including solutions of sulfur D10-3.3 µl, sulfur D4-3.3 µl, vincetoxicum hirundinariaD6-6.6 µl, vincetoxicum hirundinaria D30-6.6 µl, vincetoxicum hirundinaria D10-6.6 µl, powder of nanodiamonds of 4…10 nm in an amount of 0.1 g in 0.9% NaCl solution up to 1.1 ml, the treatment course is 30 days.
MDS20140122A 2014-09-16 2014-09-16 Method for treating genital herpes MD930Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20140122A MD930Z (en) 2014-09-16 2014-09-16 Method for treating genital herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20140122A MD930Z (en) 2014-09-16 2014-09-16 Method for treating genital herpes

Publications (2)

Publication Number Publication Date
MD930Y true MD930Y (en) 2015-07-31
MD930Z MD930Z (en) 2016-02-29

Family

ID=53773727

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20140122A MD930Z (en) 2014-09-16 2014-09-16 Method for treating genital herpes

Country Status (1)

Country Link
MD (1) MD930Z (en)
  • 2014

Also Published As

Publication number Publication date
MD930Z (en) 2016-02-29

Similar Documents

Publication Publication Date Title
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
PH12018500097A1 (en) Combination of pd-1 antagonist with an egfr inhibitor
MX2021002321A (en) Novel methods.
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
SG10201811185YA (en) Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
PH12015502615B1 (en) Chemical compounds
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
TW201613578A (en) Pharmaceutical combinations
MY176246A (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
PH12016502352A1 (en) Pharmaceutical composition
MX2017015936A (en) New pharmaceutical composition comprising non-ionic surfactants.
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
EA032654B9 (en) [1,2,4]TRIAZOLO[4,3-b]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
ZA201906153B (en) Pharmaceutical compositions for combination therapy
MD930Y (en) Method for treating genital herpes
MD20140110A2 (en) Medicinal agent for the treatment of mastitis in bovine animals and preparation process thereof
SG10201809280PA (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
MX2018011512A (en) Use of insulin for promoting gastric emptying.
MX2018015240A (en) Compositions comprising timolol and their use in the treatment of rosacea by topical administration.
MD871Y (en) Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer
IN2013MU01222A (en)

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees